Robinson Value Management’s Biogen BIIB Stock Holding History

Robinson Value Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-793	Closed	-$205K	–	73
2023 Q4	$205K	Hold	793	–	–	0.13%	58
2023 Q3	$204K	Hold	793	–	–	0.15%	57
2023 Q2	$226K	Hold	793	–	–	0.16%	56
2023 Q1	$220K	Hold	793	–	–	0.17%	56
2022 Q4	$220K	Hold	793	–	–	0.19%	58
2022 Q3	$212K	Hold	793	–	–	0.21%	60
2022 Q2	$162K	Hold	793	–	–	0.15%	57
2022 Q1	$167K	Hold	793	–	–	0.13%	60
2021 Q4	$190K	Hold	793	–	–	0.16%	60
2021 Q3	$224K	Hold	793	–	–	0.2%	59
2021 Q2	$275K	Sell	793 -7,079	-90%	-$2.14M	0.22%	58
2021 Q1	$2.2M	Sell	7,872 -410	-5%	-$111K	1.81%	21
2020 Q4	$2.03M	Buy	+8,282	New	+$2.14M	1.93%	24
2019 Q4	$2.38M	Buy	+8,008	New	+$2.22M	2.27%	18
2019 Q2	$1.97M	Buy	+8,421	New	+$1.94M	1.88%	22

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Robinson Value Management's BIIB Position: Q1 2024 in Review

Robinson Value Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 793 shares — an estimated $205K sold.

Robinson Value Management first reported a position in BIIB in Q2 2019 and held it in 15 quarters. The position peaked at $2.38M in Q4 2019. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Robinson Value Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
Robinson Value Management sold 793 Biogen shares in Q1 2024, an estimated $205K.
Robinson Value Management first reported a position in Biogen in Q2 2019 and held it in 15 quarters.
Robinson Value Management's Biogen position peaked at $2.38M in Q4 2019.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Robinson Value Management's 13F filing for Q1 2024, filed 15 Apr 2024.